In situ hybridization in clinical pathology: significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancer
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
2012
|
| In: |
Der Pathologe
Year: 2012, Jahrgang: 33, Heft: 2, Pages: 307-310 |
| ISSN: | 0172-8113 |
| Online-Zugang: |
|
| Verfasserangaben: | Gaiser, T.; Rueschoff, J.; Moll, R. |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1631050281 | ||
| 003 | DE-627 | ||
| 005 | 20220815164448.0 | ||
| 007 | tu | ||
| 008 | 130131s2012 xx ||||| 00| ||ger c | ||
| 035 | |a (DE-627)1631050281 | ||
| 035 | |a (DE-576)378226193 | ||
| 035 | |a (DE-599)BSZ378226193 | ||
| 035 | |a (OCoLC)1341049791 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gaiser, Timo |d 1975- |0 (DE-588)1030402280 |0 (DE-627)735221685 |0 (DE-576)378226533 |4 aut | |
| 240 | 1 | 0 | |a In-situ-Hybridisierung in der klinischen Pathologie <engl.> |
| 245 | 1 | 0 | |a In situ hybridization in clinical pathology |b significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancer |c Gaiser, T.; Rueschoff, J.; Moll, R. |
| 264 | 1 | |c 2012 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Rüschoff, Jan Hendrik |0 (DE-588)1023363151 |0 (DE-627)718364813 |0 (DE-576)36670009X |4 aut | |
| 700 | 1 | |a Moll, Roland |0 (DE-588)1160910472 |0 (DE-627)1024313603 |0 (DE-576)506249298 |4 aut | |
| 700 | 1 | 2 | |a Gaiser, Timo |d 1975- |t In-situ-Hybridisierung in der klinischen Pathologie <engl.> |
| 773 | 0 | 8 | |i In |t Der Pathologe |d Berlin : Springer Medizin, 1979 |g 33(2012), 2, Supplement, Seite 307-310 |w (DE-627)129332771 |w (DE-600)135954-X |w (DE-576)014595117 |x 0172-8113 |7 nnas |a In situ hybridization in clinical pathology significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancer |
| 773 | 1 | 8 | |g volume:33 |g year:2012 |g number:2 |g supplement:Supplement |g pages:307-310 |g extent:4 |a In situ hybridization in clinical pathology significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancer |
| 951 | |a AR | ||
| 992 | |a 20130131 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1030402280 |a Gaiser, Timo |m 1030402280:Gaiser, Timo |d 60000 |d 63400 |e 60000PG1030402280 |e 63400PG1030402280 |k 0/60000/ |k 1/60000/63400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1631050281 |e 3281310397 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"4 S."}],"titleUni":[{"title_sort":"In-situ-Hybridisierung in der klinischen Pathologie <engl.>","title":"In-situ-Hybridisierung in der klinischen Pathologie <engl.>"}],"relHost":[{"title":[{"title_sort":"Pathologe","subtitle":"Organ der Deutschen Abteilung der Internationalen Akademie für Pathologie, der Deutschen, der Österreichischen und der Schweizerischen Gesellschaft für Pathologie und des Berufsverbandes Deutscher Pathologen","title":"Der Pathologe"}],"pubHistory":["1.1979/80(1979) -Band 43, Heft 3 (Mai 2022)"],"part":{"extent":"4","text":"33(2012), 2, Supplement, Seite 307-310","volume":"33","issue":"2","pages":"307-310","year":"2012"},"titleAlt":[{"title":"Die Pathologie"}],"type":{"bibl":"periodical"},"disp":"In situ hybridization in clinical pathology significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancerDer Pathologe","recId":"129332771","language":["ger"],"origin":[{"dateIssuedKey":"1979","publisher":"Springer Medizin ; Springer ; Springer-Medizin","dateIssuedDisp":"1979-[2022]","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; Heidelberg"}],"id":{"issn":["0172-8113"],"eki":["129332771"],"zdb":["135954-X"]},"physDesc":[{"noteFormat":"28 cm"}]}],"name":{"displayForm":["Gaiser, T.; Rueschoff, J.; Moll, R."]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"id":{"eki":["1631050281"]},"type":{"bibl":"article-journal"},"language":["ger"],"recId":"1631050281","person":[{"family":"Gaiser","given":"Timo","display":"Gaiser, Timo","role":"aut"},{"given":"Jan Hendrik","family":"Rüschoff","role":"aut","display":"Rüschoff, Jan Hendrik"},{"display":"Moll, Roland","role":"aut","family":"Moll","given":"Roland"},{"display":"Gaiser, Timo","family":"Gaiser","given":"Timo"}],"title":[{"title":"In situ hybridization in clinical pathology","subtitle":"significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancer","title_sort":"In situ hybridization in clinical pathology"}]} | ||
| SRT | |a GAISERTIMOINSITUHYBR2012 | ||